Wird geladen...
Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib-based chemotherapy
Nine pretreated patients aged >19 years with relapsed/refractory acute lymphoblastic leukemia (ALL) were treated with a combination of bortezomib plus chemotherapy before allogeneic hematopoietic stem cell transplantation (allo-HSCT). Eight (88.9%) patients, including two Philadelphia chromosome-...
Gespeichert in:
| Veröffentlicht in: | Int J Gen Med |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4472074/ https://ncbi.nlm.nih.gov/pubmed/26109875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S59537 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|